We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+0.87%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$220M
AUM Growth
+$3.2M
Cap. Flow
+$2.23M
Cap. Flow %
1.02%
Top 10 Hldgs %
43.16%
Holding
72
New
2
Increased
21
Reduced
30
Closed
2

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$946K
2
PYPL icon
PayPal
PYPL
+$752K
3
META icon
Meta Platforms (Facebook)
META
+$646K
4
ABT icon
Abbott
ABT
+$591K
5
PAYC icon
Paycom
PAYC
+$242K

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$648K
2
APD icon
Air Products & Chemicals
APD
+$559K
3
LLTC
Linear Technology Corp
LLTC
+$309K
4
GILD icon
Gilead Sciences
GILD
+$217K
5
CMG icon
Chipotle Mexican Grill
CMG
+$103K

Sector Composition

Rank Sector Weight
1 Healthcare 23.48%
2 Technology 18.99%
3 Consumer Staples 14.95%
4 Industrials 9.98%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$13.6M 6.18%
469,088
-2,636
-0.6% -$74.7K
SYK icon
2
Stryker
SYK
$125B
$12.1M 5.5%
100,867
-45
-0% -$5.18K
ADP icon
3
Automatic Data Processing
ADP
$106B
$9.79M 4.45%
95,092
-234
-0.2% -$21.8K
CL icon
4
Colgate-Palmolive
CL
$73.1B
$9.41M 4.28%
144,808
-26
-0% -$1.78K
PAYX icon
5
Paychex
PAYX
$41.6B
$9.4M 4.28%
154,187
-400
-0.3% -$23K
V icon
6
Visa
V
$684B
$9.17M 4.17%
117,562
-211
-0.2% -$17K
PEP icon
7
PepsiCo
PEP
$190B
$8.6M 3.91%
81,860
+50
+0.1% +$5.24K
ABBV icon
8
AbbVie
ABBV
$443B
$7.92M 3.6%
125,651
-404
-0.3% -$24.7K
ABT icon
9
Abbott
ABT
$183B
$7.53M 3.42%
198,036
+14,898
+8% +$591K
JNJ icon
10
Johnson & Johnson
JNJ
$618B
$7.41M 3.37%
64,402
-455
-0.7% -$52.6K
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.36T
$7.21M 3.28%
182,140
+3,040
+2% +$122K
APD icon
12
Air Products & Chemicals
APD
$65.7B
$6.84M 3.11%
47,475
-3,991
-8% -$559K
SBUX icon
13
Starbucks
SBUX
$120B
$6.37M 2.89%
113,667
+1,355
+1% +$75.1K
CNI icon
14
Canadian National Railway
CNI
$76.9B
$5.57M 2.53%
83,069
+80
+0.1% +$5.28K
RTX icon
15
RTX Corp
RTX
$290B
$5.41M 2.46%
78,090
-435
-0.6% -$28.8K
LOW icon
16
Lowe's Companies
LOW
$117B
$5.36M 2.44%
75,446
+270
+0.4% +$19.1K
NVO
17
Novo Nordisk
NVO
$208B
$5.08M 2.31%
282,014
+52,206
+23% +$946K
CELG
18
DELISTED
Celgene Corp
CELG
$5.06M 2.3%
43,590
+595
+1% +$66.3K
DIS icon
19
Walt Disney
DIS
$167B
$4.74M 2.15%
45,551
+1,155
+3% +$113K
UPS icon
20
United Parcel Service
UPS
$88.6B
$4.73M 2.15%
41,095
– –
PG icon
21
Procter & Gamble
PG
$336B
$4.7M 2.14%
55,943
-356
-0.6% -$30.3K
ECL icon
22
Ecolab
ECL
$78.1B
$4.54M 2.06%
38,764
-37
-0.1% -$4.33K
NSC icon
23
Norfolk Southern
NSC
$75.4B
$4.47M 2.03%
41,366
+665
+2% +$67.2K
SLB icon
24
SLB Ltd
SLB
$73.6B
$4.16M 1.89%
49,471
+690
+1% +$56.6K
GOOG icon
25
Alphabet (Google) Class C
GOOG
$4.36T
$3.8M 1.73%
98,360
-300
-0.3% -$11.7K
1
2 3

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Dillon & Associates held 72 positions worth $220M, up 1.5% from $217M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Dillon & Associates's Q4 2016 filing shows 2 new, 21 increased, 30 reduced and 2 closed positions. Its largest new stake was Bristol-Myers Squibb: 3,950 shares worth $229K. The largest sale was Fortive, an estimated $648K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Staples.

  • Dillon & Associates's largest Q4 2016 buy was Bristol-Myers Squibb: 3,950 shares worth $229K.
  • Dillon & Associates added most to Novo Nordisk in Q4 2016, an estimated $946K increase.
  • Dillon & Associates's biggest Q4 2016 reduction was Air Products & Chemicals, cutting an estimated $559K.
  • Dillon & Associates fully exited Fortive in Q4 2016, selling an estimated $648K.
  • Dillon & Associates's ten largest holdings make up 43% of its $220M portfolio in Q4 2016.
  • Dillon & Associates opened 2 new positions and closed 2 in Q4 2016.
  • Dillon & Associates's portfolio value rose 1.5% quarter-over-quarter to $220M.

Based on Dillon & Associates's 13F filing for Q4 2016, filed 2 Feb 2017.